-
America’s Choice Provider Network Partners with Scipher Medicine to Improve Patient Outcomes and Lower Costs for Rheumatoid Arthritis Care -
RxParadigm Partners with Scipher Medicine® to Support Medication Utilization, Improve Patient Outcomes, and Lower Costs for Rheumatoid Arthritis Care -
Scipher Medicine® to Present at the Jeffries London Healthcare Conference - Scipher Medicine® to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
-
TARA Biosystems Partners with Scipher Medicine® -
Molecular Test Further Helps Personalize Rheumatoid Arthritis Care - Can a Blood-Based Test Predict TNFi Nonresponse in RA?
-
Scipher Medicine Introduces Breakthrough Capability to Accelerate Drug Discovery -
New Strategy for Avoiding Waste and Improving Response for Highest Cost Therapies in Rheumatoid Arthritis -
Scipher Medicine Announces Publication of Clinical Study Validating PrismRA, a Blood Test Predicting Non-Response to TNF Inhibitor Therapies in Patients with Rheumatoid Arthritis -
Pandemic versus pandemonium: fighting on two fronts -
COVID-19 might be bitter medicine for what ails AI investing -
Coronavirus: AI steps up in battle against Covid-19 -
Scipher Medicine has developed a blood test expected to save payers billions each year -
Defining response to TNF-inhibitors in rheumatoid arthritis: the negative impact of anti-TNF cycling